United States · Business magazines · Quartz
Novo Nordisk's weight loss injection cut obesity in young children, trial shows

Detailed summary
In the STEP Young trial, BMI fell an estimated 17.4% with semaglutide and rose 2.2% with placebo at week 68 among children 6 to under 12
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)




